Zurich Cantonal Bank’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,014
| Closed | -$1.65M | – | 2850 |
|
|
2021
Q2 | $1.65M | Sell |
10,014
-196
| -2% | -$32.7K | 0.01% | 772 |
|
|
2021
Q1 | $1.56M | Buy |
10,210
+2,209
| +28% | +$300K | 0.01% | 756 |
|
|
2020
Q4 | $1M | Buy |
8,001
+695
| +10% | +$77.7K | 0.01% | 954 |
|
|
2020
Q3 | $741K | Hold |
7,306
| – | – | 0.01% | 932 |
|
|
2020
Q2 | $711K | Buy |
7,306
+2,271
| +45% | +$211K | 0.01% | 884 |
|
|
2020
Q1 | $418K | Buy |
5,035
+377
| +8% | +$36.8K | ﹤0.01% | 919 |
|
|
2019
Q4 | $518K | Buy |
4,658
+783
| +20% | +$80.5K | ﹤0.01% | 914 |
|
|
2019
Q3 | $385K | Buy |
3,875
+485
| +14% | +$48.2K | ﹤0.01% | 970 |
|
|
2019
Q2 | $336K | Sell |
3,390
-373
| -10% | -$35.6K | ﹤0.01% | 1017 |
|
|
2019
Q1 | $415K | Sell |
3,763
-185
| -5% | -$19.3K | ﹤0.01% | 927 |
|
|
2018
Q4 | $363K | Buy |
3,948
+467
| +13% | +$47.3K | ﹤0.01% | 963 |
|
|
2018
Q3 | $384K | Buy |
3,481
+412
| +13% | +$42.9K | ﹤0.01% | 999 |
|
|
2018
Q2 | $287K | Hold |
3,069
| – | – | ﹤0.01% | 1068 |
|
|
2018
Q1 | $255K | Hold |
3,069
| – | – | ﹤0.01% | 1080 |
|
|
2017
Q4 | $279K | Buy |
3,069
+1,388
| +83% | +$115K | ﹤0.01% | 1019 |
|
|
2017
Q3 | $128K | Buy |
1,681
+193
| +13% | +$14.6K | ﹤0.01% | 1249 |
|
|
2017
Q2 | $112K | Buy |
1,488
+160
| +12% | +$11.1K | ﹤0.01% | 1306 |
|
|
2017
Q1 | $87K | Hold |
1,328
| – | – | ﹤0.01% | 1457 |
|
|
2016
Q4 | $73K | Sell |
1,328
-697
| -34% | -$38.3K | ﹤0.01% | 1492 |
|
|
2016
Q3 | $114K | Buy |
2,025
+133
| +7% | +$6.52K | ﹤0.01% | 1183 |
|
|
2016
Q2 | $79K | Buy |
1,892
+1,140
| +152% | +$52.5K | ﹤0.01% | 1278 |
|
|
2016
Q1 | $32K | Hold |
752
| – | – | ﹤0.01% | 1701 |
|
|
2015
Q4 | $34K | Buy |
752
+519
| +223% | +$21.8K | ﹤0.01% | 1680 |
|
|
2015
Q3 | $9K | Buy |
+233
| New | +$9.33K | ﹤0.01% | 2148 |
|
Other funds holding PRAH
Zurich Cantonal Bank's PRAH Position: Q3 2021 in Review
Zurich Cantonal Bank sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 10,014 shares — an estimated $1.65M sold.
Zurich Cantonal Bank first reported a position in PRAH in Q3 2015 and held it in 24 quarters. The position peaked at $1.65M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Zurich Cantonal Bank reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Zurich Cantonal Bank sold 10,014 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.65M.
- Zurich Cantonal Bank first reported a position in PRA Health Sciences, Inc. in Q3 2015 and held it in 24 quarters.
- Zurich Cantonal Bank's PRA Health Sciences, Inc. position peaked at $1.65M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Zurich Cantonal Bank's 13F filing for Q3 2021, filed 15 Nov 2021.